U.S. Basic Materials Stock News

NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Stock Looks Like A Bargain On Cash Flow And Earnings

Boston Scientific stock has fallen sharply over the past year, yet several valuation checks now suggest the shares may be pricing in a lot of bad news already. The market reaction to the recent cyberattack and softer demand for key products has been severe, while both intrinsic value estimates and market multiples currently lean more supportive. The stock is down 54.5% over the past year, which points to a heavy reset in expectations for Boston Scientific. The recent cyberattack and...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (BIDU) Stock Looks Expensive On Cash Flow But Cheap On Sales

Baidu stock has spent the past five years in decline, yet current valuation checks send conflicting messages, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade at a premium while market multiples point to a discount. That split leaves investors weighing how much faith to place in Baidu’s cash flow profile compared with what the market is willing to pay today. The share price is down about 43.5% over five years, which means longer term investors are still...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

Is Patterson-UTI’s New Omnibus Shelf Registration Reshaping the Investment Case for PTEN?

In the past few days, Patterson-UTI Energy filed an omnibus shelf registration that covers potential issuances of debt securities, preferred stock, common stock, and warrants. This broad financing framework increases Patterson-UTI Energy’s flexibility to raise capital across multiple instruments as conditions and funding needs evolve. We’ll explore how this expanded capital-raising flexibility may affect Patterson-UTI Energy’s investment narrative, especially its technology and...
NYSE:ENS
NYSE:ENSElectrical

EnerSys’ Bolt‑On Acquisition Push and Upgraded Estimates Might Change The Case For Investing In ENS

In August 2026, EnerSys (NYSE: ENS) reported on its fiscal 2027 first quarter earnings call that it is actively pursuing accretive bolt-on acquisitions aimed at deepening customer relationships, enhancing technical capabilities, and accelerating its growth strategy in markets where it believes it has a right to win. An interesting angle is how this acquisition appetite coincides with recently improved technical sentiment and earnings estimates, potentially giving EnerSys more flexibility to...
NYSE:ORI
NYSE:ORIInsurance

Old Republic International (ORI) Lifts Dividend As A Modest Undervalued View Stays In Focus

Old Republic International (ORI) has caught investor attention after its Board declared a regular quarterly dividend of $0.315 per share, implying a full-year payout of $1.26, an 8.6% increase over the 2025 level. Old Republic International's recent dividend decision comes as the stock trades at US$42.45, with short term share price momentum easing over the past month. However, a 90 day share price return of 12.45%, a 1 year total shareholder return of 15.56%, and a 5 year total shareholder...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore (EVR), What Is Drawing Fresh Attention To The Stock?

Options activity puts Evercore in focus Recent trading in Evercore (EVR) options, where the September 18, 2026 $165 call shows elevated implied volatility, has put the stock on many investors’ radar as markets price in potential share price swings. At a share price of $291.42, Evercore has seen the share price fall 14.3% over the past month and 17.0% year to date, while the 5 year total shareholder return of 126.6% points to a much stronger longer term picture. Recent weakness in the share...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Oracle Stock And Palantir Shares Stand Out For High Growth Investors

Euro-area private credit is expanding as households and companies borrow more, which points to easier financial conditions and a friendlier backdrop for growth focused businesses. That puts a spotlight on healthy high growth potential stocks where analysts already expect strong earnings momentum and solid balance sheets. This article breaks down three picks from the screener so you can see how they fit this theme and decide which deserve a closer look. The stocks covered below are just a...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group (NBIS) Adds UK AI Infrastructure In South Wales

Nebius Group (NasdaqGS: NBIS) announced a new partnership with Vantage Data Centers to deploy NVIDIA-powered AI infrastructure at the CWL1 campus in South Wales. The expansion increases Nebius Group's UK AI footprint and aligns with the region's status as a UK AI Growth Zone. The CWL1 deployment is intended to support enterprise and public sector AI workloads in line with the UK Government's AI Opportunities Action Plan. This kind of build out in UK AI infrastructure is part of a wider...
NYSE:INFQ
NYSE:INFQTech

Infleqtion (INFQ) Stock Looks Above Fair Value With Strong Quantum Progress

Infleqtion stock has surged over the past month, yet the broader valuation checks still flag the shares as expensive rather than a clear bargain. The stock has gained 38.6% over the past month, which leaves investors asking how much of the near term optimism is already reflected in the price. Recent milestones in quantum computing and sensing, including work on Japan's "Shunkai" system and new facilities in Colorado, can support confidence in Infleqtion's long term commercial opportunity. At...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Did Positive Vibrance-1 Data and Brilliance Phase 3 Launch Just Shift Alkermes' (ALKS) Investment Narrative?

Alkermes recently reported that data from its Phase 2 Vibrance-1 study of oral orexin 2 receptor agonist alixorexton in adults with narcolepsy type 1 were published in The Lancet Neurology, showing statistically significant improvements in wakefulness, excessive daytime sleepiness, and cataplexy versus placebo with a generally well-tolerated safety profile. The positive Phase 2 results have already led Alkermes to launch a global Phase 3 Brilliance program in narcolepsy and secured both...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon Athletica (LULU) Heads Into Earnings As Investors Weigh Value Against Slowing Sales

Lululemon Athletica (LULU) heads into its Sept. 3 second quarter earnings report with mixed expectations, as analysts weigh cost control and buybacks against weaker US and China sales and cautious sector commentary. That debate is playing out against a weak price backdrop. Lululemon athletica’s share price is down 44.8% year to date and the 1-year total shareholder return has declined 43.4%, with the 3- and 5-year total shareholder returns also showing large cumulative declines. This suggests...
NYSE:AOS
NYSE:AOSBuilding

High Dividend U.S. Value Stocks Investors Are Turning To As Rates Stay Higher

With July PCE inflation running hotter than expected and the 10 year Treasury yield near 4.67%, many growth stocks are feeling the pressure, while cash rich, dividend paying companies with modest valuations are drawing fresh attention. This article looks at how that backdrop and the coming Fed signals could affect three U.S. value stocks exposed to these rate and inflation headlines, and why their mix of income and balance sheet strength may matter to you now. The stocks in the list below are...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Peloton Interactive (PTON), What Is Behind The Fresh Attention?

Fresh interest in Peloton Interactive (PTON) has been stirred by new research on the global modular fitness furniture market, which highlights growing home-based fitness adoption, urban space constraints, and wellness-focused consumer habits. Peloton Interactive’s share price, which last closed at US$5.36, has been under pressure, with the 30 day share price return down 14.38% and the year to date share price return down 12.42%. The 1 year total shareholder return is down 30.21%, signalling...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

SkyWest (SKYW) Stock Looks Reasonable Even After A 144% Run

SkyWest stock has given investors a strong ride over the past three years, yet recent weakness has raised the question of whether the current price properly reflects the company’s fundamentals. With a high value score and an undervalued read on market multiples, the stock’s recent pullback contrasts with the longer term share price performance. SkyWest has returned about 143.8% over the past three years, which signals that the stock has already rewarded investors who held through that...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Why Microchip Technology (MCHP) Is Back In The Spotlight

Microchip Technology (MCHP) recently expanded its atomic clock line with the Space CSAC-SA65, a compact, radiation-tolerant timing device aimed at Low Earth Orbit satellites and other space systems. Alongside this product launch, Microchip Technology’s share price has been under pressure in recent months, with a 30 day share price return of down 4.9% and a 90 day share price return of down 22.9%, even though the year to date share price return is up 13.9% and the 1 year total shareholder...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

Werner Enterprises (WERN) Rings Nasdaq Closing Bell, Is The Stock Still Trading At A Discount?

Werner Enterprises rings Nasdaq Closing Bell and draws investor attention Werner Enterprises (WERN) marked its 70th anniversary and 40 years as a public company by ringing the Nasdaq Closing Bell on August 27, a ceremonial milestone that can prompt investors to revisit the stock. Werner Enterprises shares closed at US$38.89, with a 1-day share price return of 3.32% and a 7-day share price return of 2.45%. The stock is down over the past 3 months. However, a 27.05% year to date share price...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Is Monte Rosa Therapeutics (GLUE) Redefining Its Prostate Cancer Strategy With MRT-2359’s Phase 2 Combo Bet?

Monte Rosa Therapeutics, Inc. recently dosed the first patient in MODeFIRe-1, a Phase 2 trial of its investigational molecular glue degrader MRT-2359 combined with apalutamide in metastatic castration-resistant prostate cancer patients with androgen receptor mutations. This study builds on earlier combination data with enzalutamide and uses a Simon’s two-stage design to test MRT-2359 in a genetically defined, heavily pretreated prostate cancer population. We will now examine how advancing...
NYSE:GLW
NYSE:GLWElectronic

How Corning’s Highlighted Earnings Strength Versus Peers Will Impact Corning (GLW) Investors

In recent coverage prior to today, Corning (GLW) was highlighted as a high‑flying stock with strong fundamentals, including exceptional revenue growth and improving earnings per share relative to peers facing financial pressures. This positive spotlight has sharpened investor focus on Corning’s operational strength versus sector names struggling with cash burn and weaker profitability profiles. Next, we’ll examine how this recognition of Corning’s improving earnings profile may influence its...
NasdaqGS:SPCX
NasdaqGS:SPCXTelecom

Space Exploration Technologies (SPCX) Plans $100 Billion Starbase Louisiana Project

Space Exploration Technologies (NasdaqGS:SPCX) plans to invest US$100b in a new Starbase Louisiana launch facility, described as its largest infrastructure project to date. The Starbase Louisiana site is expected to become SpaceX's largest launch complex, with a multi year build out and operational scale up for Starship missions and satellite activity. SpaceX announced a partnership with Nvidia to power orbital AI data centers that are intended to support a planned million satellite network...
NYSE:AMT
NYSE:AMTSpecialized REITs

Is American Tower (AMT) Cheap After Its Recent Mixed Share Price Performance?

American Tower’s recent performance in focus American Tower (AMT) stock has drawn attention after a mixed stretch for shareholders, with a modest gain over the past month offset by a decline over the past 3 months and the past year. Over a 5 year period the total return has also declined, while the 3 year total return remains positive. This contrasting picture is encouraging some investors to reassess how the current share price lines up with American Tower’s fundamentals. At a share price of...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target (TGT) Following Strong Q2 And Beauty Push While Fair Value Stays Cautious

Target (TGT) is back in focus after two key developments. The company reported Q2 results with higher sales and earnings, and introduced Target Beauty Studio, a new premium beauty concept set to roll out in September. Target’s recent news is landing on a stock that already has strong momentum, with a 30 day share price return of 16.89% and a year to date share price return of 63.21%. The 1 year total shareholder return of 74.24% shows how quickly sentiment has shifted, despite a weaker 5 year...
NasdaqGS:LSTR
NasdaqGS:LSTRTransportation

Landstar System (LSTR) Could Be 8% Undervalued As Insurance Costs Rise

TD Cowen’s recent commentary on rising broker insurance costs after the Montgomery decision puts Landstar System (LSTR) in focus, as investors weigh higher liability exposure and potential consolidation among freight brokers. Against this legal backdrop, Landstar System’s share price has been volatile, with a 1 day share price return of 1.76% but a 90 day share price return that is down 12.21%. At the same time, the year to date share price return of 23.74% and 1 year total shareholder return...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Sandisk (SNDK) Rebounds With Tech, Is The Stock Still A Bargain?

Sandisk (SNDK) is back in focus after broader tech stocks rebounded, with memory and data storage companies recovering some ground as Treasury yields and oil prices eased and growth names drew fresh interest. After a sharp pullback earlier in the week, Sandisk’s 1 day share price return of 1.26% and 30 day share price return of 17.30% suggest short term momentum is rebuilding, even as the 90 day share price return is down 8.67%. The very large 1 year total shareholder return highlights how...
NYSE:KOS
NYSE:KOSOil and Gas

Cost Discipline And Production Push Might Change The Case For Investing In Kosmos Energy (KOS)

Kosmos Energy recently reiterated its focus on lifting production from core offshore assets in Ghana, Mauritania and Senegal, and the Gulf of Mexico, while tightening operating costs, reducing debt, and keeping near-term development spending in check. An interesting angle for investors is how this combination of cost discipline, deleveraging, and production-focused investment sits alongside analyst expectations for meaningful earnings growth by 2026. With this renewed emphasis on production...